Huimin Qu

State Key Laboratory Of Vaccines For Infectious Diseases, State Key Laboratory Of Molecular Vaccinology And Molecular Diagnostics, No. 4221-117 South Xiang'an Road, Xiang'an District
Xiamen, 361102, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

A Human Mobility-Based Modeling Study of Influenza Vaccination Strategies Across Socioeconomically Disparate Regions in China.

A Human Mobility-Based Modeling Study of Influenza Vaccination Strategies Across Socioeconomically Disparate Regions in China.

Journal: Vaccines

Published: April 09, 2026

Epidemiological impact of three major respiratory coronavirus epidemics on influenza transmission: a multicountry analysis using surveillance data and mathematical modelling.

Epidemiological impact of three major respiratory coronavirus epidemics on influenza transmission: a multicountry analysis using surveillance data and mathematical modelling.

Journal: BMJ open

Published: November 12, 2025

Epidemiological features and risk factors of SARS-CoV-2 reinfection: a retrospective cohort analysis in Xiamen, China.

Epidemiological features and risk factors of SARS-CoV-2 reinfection: a retrospective cohort analysis in Xiamen, China.

Journal: Journal of thoracic disease

Published: October 10, 2024

Predicting influenza in China from October 1, 2023, to February 5, 2024: A transmission dynamics model based on population migration.

Predicting influenza in China from October 1, 2023, to February 5, 2024: A transmission dynamics model based on population migration.

Journal: Infectious Disease Modelling

Published: January 30, 2024

Temporal shifts in 24 notifiable infectious diseases in China before and during the COVID-19 pandemic.

Temporal shifts in 24 notifiable infectious diseases in China before and during the COVID-19 pandemic.

Journal: Nature communications

Published: November 19, 2023

Inactivated vaccine effectiveness against symptomatic COVID-19 in Fujian, China during the Omicron BA.2 outbreak.

Inactivated vaccine effectiveness against symptomatic COVID-19 in Fujian, China during the Omicron BA.2 outbreak.

Journal: Frontiers in public health

Published: July 29, 2023

Assessment of transmissibility and measures effectiveness of SARS in 8 regions, China, 2002-2003.

Assessment of transmissibility and measures effectiveness of SARS in 8 regions, China, 2002-2003.

Journal: Frontiers in cellular and infection microbiology

Published: April 26, 2023

Trends in disease burden of hepatitis B infection in Jiangsu Province, China, 1990-2021.

Trends in disease burden of hepatitis B infection in Jiangsu Province, China, 1990-2021.

Journal: Infectious Disease Modelling

Published: April 06, 2023

Viral dynamics of omicron BA.2.76 variant of SARS-CoV-2 in a cohort of COVID-19 patients.

Viral dynamics of omicron BA.2.76 variant of SARS-CoV-2 in a cohort of COVID-19 patients.

Journal: The Journal of infection

Published: November 26, 2022

Dynamic and classifier-based model SARS-CoV-2 Omicron spillover risk assessment in China.

Dynamic and classifier-based model SARS-CoV-2 Omicron spillover risk assessment in China.

Journal: Fundamental research

Published: September 26, 2022

Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention.

Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention.

Journal: Archives of medical science : AMS

Published: August 11, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026